This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Endocrine Testing Market

Market Insights on Endocrine Testing covering sales outlook, demand forecast & up-to-date key trends

Endocrine Testing Market by Test Type, Technology, End-use & Regional Forecast till 2023-2033

Endocrine Testing Market Snapshot (2023-2033)

The global endocrine testing market is currently valued at US$ 2536.7 Million and is anticipated to expand at a CAGR of 8.5%. With the rising prevalence of diabetes, and the rise in the geriatric population, the market is likely to propel to US$ 5735 Million by 2032.

“Emerging endocrine disorders, self-testing pregnancy kits, and favorable government policies are likely to drive the growth of the endocrine testing market in the forecast period.”

Report Attribute

Details

Expected Market Value (2022)

US$ 2536.7 Million

Projected Forecast Value (2032)

US$ 5735 Million

Global Growth Rate (2023-2033)

8.5% CAGR

Customize this Report

Let us know your requirement to get
100% FREE customization

Endocrine Testing Revenue Analysis 2018-2022 vs. Future Outlook 2023-2033

According to market research and competitive intelligence provider FMI, the endocrine testing industry grew at a CAGR of 8.3% from 2017 to 2021. Medical professionals use endocrine testing to diagnose endocrine disorders and treat the condition or disease accordingly. Innovating therapies, technologies, and advancing diagnostic methods will contribute to the market's growth.

New policies are being briefed for testing methods to detect endocrine disruptors. For example, EURION, a cluster of emerging ED research projects, published the research note. As part of EURION, eight research projects are collaborating to develop methods and determine test strategies for understudied disorders caused by EDs, such as metabolic, brain, thyroid, and reproductive problems. More than 70 research groups have partnered with the EC Horizon 2020-funded cluster since its launch in 2019, bringing over €50 million of funding and more than 50 years of experience together.

With the world returning to normalcy after the pandemic, self-test pregnancy kits are only set to become more popular. Moreover, advancements are being made in the development of endocrine testing devices that measure the level of hormones produced by the human body's endocrine glands.

What Market Trends Are Influencing the Endocrine Testing Market?

Increased Defense Spending to Bolster Demand for Endocrine Testing’s

Medical and clinical diagnostic research and development (R&D), along with new technologies that are intended to improve patient outcomes, are among the factors driving the growth of endocrine testing worldwide. As consumers demand point-of-care facilities and home-based testing kits for a wide range of health-related issues, the market has grown substantially in the last few years.

As the prevalence of endocrine disorders continues to rise along with advances in diagnostic methods, the market will grow at a significant rate. In addition, the trend of an aging population worldwide, coupled with increased awareness about the importance of early diagnosis and prevention, will be expected to lead to the growth of this market. Tests to diagnose disorders like obesity, diabetes, and thyroid disease are carried out by measuring the level of hormones secreted by the endocrine glands.

WHO estimates that there are 650 million adults, 340 million adolescents, and 39 million children worldwide who are dealing with obesity, and this number is growing at an alarming rate. Overweight or obesity is predicted to affect the health of 167 million adults and children by 2025. Endocrine testing of thyroid function is more likely to be adopted as a result, resulting in further market growth for the product.

Technological advancement to drive the Endocrine Testing market growth during the forecast period.

Increasing adoption of biosensors and digital test kits in pregnancy test kits and fertility test kits is expected to encourage the growth of the endocrine testing market.

During the testing, imbalances in hormone concentrations can be detected which can lead to chronic diseases. It is highly recommended to conduct periodic testing, particularly in elderly patients, in order to minimize the risk of developing complications or aggravating the disease. Investing in advanced endocrine testing techniques and diagnostic tests for the endocrine system will rise due to immunoassays remaining the most commonly used method to evaluate hormonal disorders. Also, investing in the integration of advanced endocrine testing techniques and diagnostic tests for endocrine systems will rise.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What Factors are the Limiting the Growth of the Endocrine Testing Market?

Stringent Regulations and the High Cost of Technologies May Impede the Growth of the Market

The high costs of developing and commercializing endocrine tests, including analyses of several hormone-stimulated cellular mechanisms, pose a challenge to manufacturers. Thus, it is inevitable that monitoring and diagnosing the secretion levels of hormones in the human body will result in a high cost to the patient.

However, because of the lack of qualified and skilled professionals in this field, the market growth is restricted due to narrow diagnostic capabilities. Endocrine function testing requires skilled as well as technical expertise due to sample handling and preparation stages. In the absence of a technical force that can perform endocrine testing with precision, the quality of the test will eventually be compromised, resulting in poor patient outcomes.

Endocrine testing solutions and methodologies are developed and introduced successfully because of improved access to sophisticated technological platforms. Government regulations restricting the development of diagnostic tests for endocrine systems and approval before they can be sold would raise costs, limiting the market growth. Because of this limitation, it deprived patients of being able to access advanced diagnostic procedures in order to receive quality diagnostic measures and decrease their chances of improving their quality of life. Consequently, high costs associated with testing technology could hamper the growth of the endocrine testing market.

Country-wise Analysis

What Role does North America Play in Global Endocrine Testing?

Research & Development Investments and Diagnostic Advancements in the Region Provide Growth Opportunities

As the top market for endocrine testing, North America is expected to show a CAGR of 47.2% through the forecast period. A significant increase in R&D investments has encouraged the development of new products for endocrinology lab tests, which is expected to augment the growth of the North American endocrinology lab tests market in the coming years.

The adoption of new technologies and the continued reform of endocrine testing projects in numerous countries are expected to boost endocrine testing in the region over the forecast period.

Additionally, major manufacturers' R&D programs and technological advances in the US and Canada resulted in major advancements.

A growing number of thyroid cases are being diagnosed globally throughout the world, and the rising prevalence of obesity is driving the global endocrine testing market. Approximately 43,800 new cases of thyroid cancer are expected to be detected in the United States in 2022 (11,860 in men and 31,940 in women) and there will be 2,230 thyroid cancer deaths (1,070 men and 1,160 women). Since thyroid cancer is common and causes many deaths in the United States, this will drive the market demand for thyroid testing in the United States.

Why is Europe emerging as an Opportunistic Endocrine Testing Market?

Governing Policies and Reimbursements in Europe to Boost the Market Growth.

In 2022, Europe is predicted to lead the endocrine testing market and will continue to do so throughout the forecast period. At present, the endocrine testing market in Europe represents 33.6% of the global market share of the endocrine testing market.

Several key factors contributing to the dominance of endocrine testing include the high prevalence of chronic endocrine disorders and reproductive health problems. The U.K., Germany, France, and Russia are expected to increase the procurement of advanced technologies, thus boosting the market.

In the UK, the reimbursement scheme is the most progressive and facilitates the rapid adoption of novel testing technologies. This allows Europe to dominate the market owing to supportive government regulations. Key market players have continued to invest in infrastructure development initiatives that are predicted to fuel global demand for endocrine testing.

How is the Asia Pacific Contributing to the Growth of the Endocrine Testing Market?

Future Growth Scope Will be Broadened by Growing Demand for Pregnancy Test Kits and Infrastructure Growth

Asia Pacific was the largest market for endocrine testing with a revenue share of 35.6% and is expected to be the largest market going forward. There are several countries that are making significant investments in home-based endocrine testing kits, including China, India, Japan, and South Korea. With the growing population base, the increasing prevalence of lifestyle-related diseases, and the development of hormonal stimulation drugs, the market is likely to continue to experience growth in the coming years.

Endocrine testing has grown in popularity with the increasing number of thyroid disorders and diabetes being diagnosed in older as well as younger generations, which has contributed to the market growth. Moreover, the government has also taken measures in the region to improve the health infrastructure and provide access to quality healthcare, which are both driving the market growth in this region.

The growth and upgrading of self-test pregnancy kits and fertility test kits in this region are expected to drive the growth of the endocrine testing market in this region. Furthermore, the growth of the market for digital pregnancy test kits, it will further contribute to the growth of the market in the future.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Country-wise Forecast CAGRs for the Endocrine Testing Market

U.K

20.3 %

India

22.5%

South Korea

16.4 %

China

19.9 %

U.S

26.4 %

Category-wise Insights

By Technology Which Segment Generates High Revenue in the Endocrine Testing market?

Immunoassay Technology Segment Generates High Revenue in the Endocrine Testing market

Based on technology immunoassay segment is projected to account for a CAGR of 18.2% in 2032. The market is expected to grow due to the increasing efficacy of antibody tests which are expected to drive market growth in the near future.

Due to the fact that there are multiple instruments and analyzers that are used for testing in order to detect the test result, different types of immunoassay technologies are utilized for the test. Moreover, there are many key players that offer immunoassay-based test panels for endocrine function and reproductive function along with many other products that contribute to the largest revenue generation in this market.

Technological advancements have led to the development of novel hormone testing methods in recent years. Nucleic acid-based detection methods, mass spectroscopy, and chromatography are becoming more widely used for endocrine testing panels and providing accurate results in a shorter time frame. All these factors will further propel market growth for the immunoassay endocrine testing market.

Which end-user segment dominates the Endocrine Testing market?

The Hospital segment is expected to grow at a high CAGR during the forecast period

In 2022, the hospital segment accounted for the largest share of 53 % and is expected to continue this trend over the forecast period. With increasing investments in healthcare infrastructure, particularly research activities, endocrine testing should see a positive impact globally.

At-home collection services and the availability of a variety of home-based test, panels are boosting the revenue generation of this segment. As a matter of fact, it is expected that hospitals will also experience the fastest growth in the following years. As health consciousness increases among individuals and endocrine testing is carried out continuously to monitor existing diseases and control hereditary conditions, this is a risk factor that can be attributed to the rise in health consciousness. Moreover, the ability to provide reports to the hospital settings over digital platforms further contributes to the growth trajectory of these hospital settings.

Start-up Scenario

How do New Entrants Contribute to the Endocrine Testing Business?

Startups are now entering the endocrine testing market, providing consumers with new products that meet their needs. Additionally, these innovative testing companies offer different kinds of endocrine testing equipment and methods, including the technologies that are used during the testing process. Several start-up companies are now focusing on the preparation of FDA-approved endocrine tests due to the popularity of FDA-approved products on the market.

  • Luminate was founded in 2012 in San Francisco, United States. A diagnostic platform that offers a toolkit to improve the quality of endocrine tests using technology. In order to provide lab results to patients and providers, Luminate Health offers a HIPAA-compliant SaaS solution. By accessing lab results online, patients can gain insights into their results. The company plans to expand into more specialized medical fields such as endocrinology, genetic testing, and oncology. As well as implementing it at retail clinics like Walgreens and Target.
  • AndroJek Key Metrics was founded in 2008 in Independence, United States. AngioJek is a biotechnology company developing novel tests to screen and diagnose male-factor infertility. Using Dr. David Brown's research, AndroJek developed sperm function tests for the diagnosis and screening of issues associated with male-factor infertility. In Reproductive Endocrinology and Urology, these tests are recommended for doctors and PhD students.
  • GenePath Diagnostics was founded in 2008, in Pune, India. Infectious diseases, cancer, and genetic disorders are some of the diseases for which the company provides diagnostic solutions. There are DNA and RNA-based tests for a wide range of applications, including infectious diseases, endocrinology, oncology, transplantation typing, pharmacogenetics, hematology, as well as prenatal and preimplantation genetic testing. Apart from HPV and COVID-19, the company also detects other infections.

Competitive Landscape

Through strategic partnerships, manufacturers can boost revenues and gain a greater share of the market by increasing production and meeting consumer demand. As a result of endocrine testing, the end user will benefit by taking advantage of new products and technologies. Expanding production capabilities can be achieved through strategic partnerships.

Key players in the global endocrine testing market include Abbott Laboratories, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories, DiaSorin S.p.A., F.Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Ortho Clinical Diagnostics.

  • In July 2022, Watchfrog Laboratory validates a new method for detecting endocrine disruptors. Test Guideline n°251 (TG n°251) contributes to identifying endocrine-disrupting chemicals through the testing strategies of the Organisation for Economic Co-operation and Development (OECD). It contributes to the discovery of chemicals that disrupt androgenic hormone signaling by using the RADAR assay TG n°251 (Rapid Androgen Disruption Activity Reporter).
  • With new partnerships, Eurofins is expanding its global innovation capabilities for endocrine disruptor characterization. As part of the PEPPER Platform, Eurofins network of companies will pre-validate methods for endocrine disruptor characterization. Several key stakeholders in the endocrine disruptor space are involved in PEPPER, including health, environmental, and industrial stakeholders

Report Scope

Report Attribute

Details

Growth Rate (2023-2033)

8.5%

Expected Market Value (2022)

US$ 2536.7 Million

Projected Forecast Value (2032)

US$ 5735 Million

Base Year for Estimation

2021

Historical Data

2018-2022

Forecast Period

2023-2033

Quantitative Units

Revenue in USD Million and CAGR from 2023-2033

Report Coverage

Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis

Segments Covered

  • Test Type
  • Technology
  • End User
  • Regions

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • MEA

Key Countries Profiled

  • U.S
  • Canada
  • Brazil
  • Mexico
  • Germany
  • U.K
  • France
  • Spain
  • Italy
  • Malaysia
  • Thailand
  • India
  • Singapore
  • GCC
  • South Africa
  • Israel

Key Companies Profiled

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories Inc.
  • AB Sciex
  • bioMerieux SA
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Incorporated
  • Ortho Clinical Diagnostics

Customization

Available Upon Request

Key Segments Covered in the endocrine testing Market Industry Survey

Endocrine Testing Market by Test Type:

  • Estradiol (E2) Test in Endocrine Testing
  • Human Chorionic Gonadotropin (hCG) Hormone Test in Endocrine Testing
  • Follicle Stimulating Hormone (FSH) Test in Endocrine Testing
  • Luteinizing Hormone (LH) Test in Endocrine Testing
  • Progesterone Test in Endocrine Testing
  • Testosterone Test in Endocrine Testing
  • Thyroid Stimulating Hormone (TSH) Test in Endocrine Testing
  • Dehydroepiandrosterone Sulfate (DHEAS) Test in Endocrine Testing
  • Prolactin Test in Endocrine Testing
  • Insulin Test in Endocrine Testing
  • Cortisol Test in Endocrine Testing
  • Others Endocrine Testing

Endocrine Testing Market by Technology:

  • Mass Spectroscopy Endocrine Testing
  • Chromatography Endocrine Testing
  • Immunoassay Endocrine Testing
  • Nucleic Acid Based Endocrine Testing

Endocrine Testing Market by End-user:

  • Endocrine Testing at Hospitals
  • Endocrine Testing at Ambulatory Care Centers
  • Endocrine Testing at Commercial Laboratories
  • Other Endocrine Testing

Endocrine Testing Market by Region:

  • North America Endocrine Testing Market
  • Latin America Endocrine Testing Market
  • Europe Endocrine Testing Market
  • South Asia Endocrine Testing Market
  • East Asia Endocrine Testing Market
  • Oceania Endocrine Testing Market
  • MEA Endocrine Testing Market

Frequently Asked Questions

The global endocrine testing market is likely to reach a valuation of US$2536.7 million by the end of 2022.

Abbott Laboratories, Agilent Technologies Inc., AB Sciex, bioMerieux SA, DiaSorin S.p.A., Bio-Rad Laboratories, F.Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated, Ortho Clinical Diagnostics and Laboratory Corporation of America Holdings.

Sales of endocrine testing market are likely to expand at 8.5% CAGR through 2032.

The U.S., Canada, India, China, and Germany are predicted to drive most of the endocrine testing market demand.

By the end of 2032, the global market for the endocrine testing market is predicted to reach a valuation of US$ 5735 Million

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Test Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Test Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Test Type, 2022-2032

        5.3.1. Estradiol (E2) Test

        5.3.2. Follicle Stimulating Hormone (FSH) Test

        5.3.3. Human Chorionic Gonadotropin (hCG) Hormone Test

        5.3.4. Luteinizing Hormone (LH) Test

        5.3.5. Dehydroepiandrosterone Sulfate (DHEAS) Test

        5.3.6. Progesterone Test

        5.3.7. Testosterone Test

        5.3.8. Thyroid Stimulating Hormone (TSH) Test

        5.3.9. Prolactin Test

        5.3.10. Cortisol Test

        5.3.11. Insulin Test

        5.3.12. Others

    5.4. Y-o-Y Growth Trend Analysis By Test Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Test Type, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Technology

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Technology, 2017-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Technology, 2022-2032

        6.3.1. Mass Spectroscopy

        6.3.2. Immunoassay

        6.3.3. Chromatography

        6.3.4. Nucleic Acid Based

    6.4. Y-o-Y Growth Trend Analysis By Technology, 2017-2021

    6.5. Absolute $ Opportunity Analysis By Technology, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End-user

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Mn) Analysis By End-user , 2017-2021

    7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-user , 2022-2032

        7.3.1. Hospitals

        7.3.2. Commercial Laboratories

        7.3.3. Ambulatory Care Centers

        7.3.4. Others

    7.4. Y-o-Y Growth Trend Analysis By End-user , 2017-2021

    7.5. Absolute $ Opportunity Analysis By End-user , 2022-2032

8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Europe

        8.3.4. South Asia

        8.3.5. East Asia

        8.3.6. Oceania

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. U.S.

            9.2.1.2. Canada

        9.2.2. By Test Type

        9.2.3. By Technology

        9.2.4. By End-user

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Test Type

        9.3.3. By Technology

        9.3.4. By End-user

    9.4. Key Takeaways

10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Test Type

        10.2.3. By Technology

        10.2.4. By End-user

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Test Type

        10.3.3. By Technology

        10.3.4. By End-user

    10.4. Key Takeaways

11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. U.K.

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Europe

        11.2.2. By Test Type

        11.2.3. By Technology

        11.2.4. By End-user

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Test Type

        11.3.3. By Technology

        11.3.4. By End-user

    11.4. Key Takeaways

12. South Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Malaysia

            12.2.1.3. Singapore

            12.2.1.4. Thailand

            12.2.1.5. Rest of South Asia

        12.2.2. By Test Type

        12.2.3. By Technology

        12.2.4. By End-user

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Test Type

        12.3.3. By Technology

        12.3.4. By End-user

    12.4. Key Takeaways

13. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Test Type

        13.2.3. By Technology

        13.2.4. By End-user

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Test Type

        13.3.3. By Technology

        13.3.4. By End-user

    13.4. Key Takeaways

14. Oceania Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        14.2.1. By Country

            14.2.1.1. Australia

            14.2.1.2. New Zealand

        14.2.2. By Test Type

        14.2.3. By Technology

        14.2.4. By End-user

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Test Type

        14.3.3. By Technology

        14.3.4. By End-user

    14.4. Key Takeaways

15. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    15.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    15.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Test Type

        15.2.3. By Technology

        15.2.4. By End-user

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Test Type

        15.3.3. By Technology

        15.3.4. By End-user

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. U.S.

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2021

            16.1.2.1. By Test Type

            16.1.2.2. By Technology

            16.1.2.3. By End-user

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2021

            16.2.2.1. By Test Type

            16.2.2.2. By Technology

            16.2.2.3. By End-user

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2021

            16.3.2.1. By Test Type

            16.3.2.2. By Technology

            16.3.2.3. By End-user

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2021

            16.4.2.1. By Test Type

            16.4.2.2. By Technology

            16.4.2.3. By End-user

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2021

            16.5.2.1. By Test Type

            16.5.2.2. By Technology

            16.5.2.3. By End-user

    16.6. U.K.

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2021

            16.6.2.1. By Test Type

            16.6.2.2. By Technology

            16.6.2.3. By End-user

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2021

            16.7.2.1. By Test Type

            16.7.2.2. By Technology

            16.7.2.3. By End-user

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2021

            16.8.2.1. By Test Type

            16.8.2.2. By Technology

            16.8.2.3. By End-user

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2021

            16.9.2.1. By Test Type

            16.9.2.2. By Technology

            16.9.2.3. By End-user

    16.10. India

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2021

            16.10.2.1. By Test Type

            16.10.2.2. By Technology

            16.10.2.3. By End-user

    16.11. Malaysia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2021

            16.11.2.1. By Test Type

            16.11.2.2. By Technology

            16.11.2.3. By End-user

    16.12. Singapore

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2021

            16.12.2.1. By Test Type

            16.12.2.2. By Technology

            16.12.2.3. By End-user

    16.13. Thailand

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2021

            16.13.2.1. By Test Type

            16.13.2.2. By Technology

            16.13.2.3. By End-user

    16.14. China

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2021

            16.14.2.1. By Test Type

            16.14.2.2. By Technology

            16.14.2.3. By End-user

    16.15. Japan

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2021

            16.15.2.1. By Test Type

            16.15.2.2. By Technology

            16.15.2.3. By End-user

    16.16. South Korea

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2021

            16.16.2.1. By Test Type

            16.16.2.2. By Technology

            16.16.2.3. By End-user

    16.17. Australia

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2021

            16.17.2.1. By Test Type

            16.17.2.2. By Technology

            16.17.2.3. By End-user

    16.18. New Zealand

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2021

            16.18.2.1. By Test Type

            16.18.2.2. By Technology

            16.18.2.3. By End-user

    16.19. GCC Countries

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2021

            16.19.2.1. By Test Type

            16.19.2.2. By Technology

            16.19.2.3. By End-user

    16.20. South Africa

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2021

            16.20.2.1. By Test Type

            16.20.2.2. By Technology

            16.20.2.3. By End-user

    16.21. Israel

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2021

            16.21.2.1. By Test Type

            16.21.2.2. By Technology

            16.21.2.3. By End-user

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Test Type

        17.3.3. By Technology

        17.3.4. By End-user

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Abbott Laboratories

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. AB Sciex

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Agilent Technologies Inc.

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. bioMerieux SA

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Bio-Rad Laboratories Inc.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. DiaSorin S.p.A.

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. F. Hoffmann-La Roche Ltd.

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

        18.1.8. Laboratory Corporation of America Holdings

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

        18.1.9. Quest Diagnostics Incorporated

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

        18.1.10. Ortho Clinical Diagnostics

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 3: Global Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 4: Global Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 5: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 7: North America Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 8: North America Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 9: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 11: Latin America Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 12: Latin America Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 13: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 15: Europe Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 16: Europe Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 17: South Asia Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: South Asia Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 19: South Asia Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 20: South Asia Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 21: East Asia Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: East Asia Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 23: East Asia Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 24: East Asia Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 25: Oceania Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: Oceania Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 27: Oceania Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 28: Oceania Market Value (US$ Mn) Forecast by End-user , 2017-2032

Table 29: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 30: MEA Market Value (US$ Mn) Forecast by Test Type, 2017-2032

Table 31: MEA Market Value (US$ Mn) Forecast by Technology, 2017-2032

Table 32: MEA Market Value (US$ Mn) Forecast by End-user , 2017-2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ Mn) by Test Type, 2022-2032

Figure 2: Global Market Value (US$ Mn) by Technology, 2022-2032

Figure 3: Global Market Value (US$ Mn) by End-user , 2022-2032

Figure 4: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 9: Global Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 10: Global Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 11: Global Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 12: Global Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 13: Global Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 14: Global Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 15: Global Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 16: Global Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 17: Global Market Attractiveness by Test Type, 2022-2032

Figure 18: Global Market Attractiveness by Technology, 2022-2032

Figure 19: Global Market Attractiveness by End-user , 2022-2032

Figure 20: Global Market Attractiveness by Region, 2022-2032

Figure 21: North America Market Value (US$ Mn) by Test Type, 2022-2032

Figure 22: North America Market Value (US$ Mn) by Technology, 2022-2032

Figure 23: North America Market Value (US$ Mn) by End-user , 2022-2032

Figure 24: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 29: North America Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 30: North America Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 31: North America Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 32: North America Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 33: North America Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 34: North America Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 35: North America Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 36: North America Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 37: North America Market Attractiveness by Test Type, 2022-2032

Figure 38: North America Market Attractiveness by Technology, 2022-2032

Figure 39: North America Market Attractiveness by End-user , 2022-2032

Figure 40: North America Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Market Value (US$ Mn) by Test Type, 2022-2032

Figure 42: Latin America Market Value (US$ Mn) by Technology, 2022-2032

Figure 43: Latin America Market Value (US$ Mn) by End-user , 2022-2032

Figure 44: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 49: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 51: Latin America Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 52: Latin America Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 54: Latin America Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 55: Latin America Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 57: Latin America Market Attractiveness by Test Type, 2022-2032

Figure 58: Latin America Market Attractiveness by Technology, 2022-2032

Figure 59: Latin America Market Attractiveness by End-user , 2022-2032

Figure 60: Latin America Market Attractiveness by Country, 2022-2032

Figure 61: Europe Market Value (US$ Mn) by Test Type, 2022-2032

Figure 62: Europe Market Value (US$ Mn) by Technology, 2022-2032

Figure 63: Europe Market Value (US$ Mn) by End-user , 2022-2032

Figure 64: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 69: Europe Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 70: Europe Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 71: Europe Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 72: Europe Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 73: Europe Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 74: Europe Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 75: Europe Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 76: Europe Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 77: Europe Market Attractiveness by Test Type, 2022-2032

Figure 78: Europe Market Attractiveness by Technology, 2022-2032

Figure 79: Europe Market Attractiveness by End-user , 2022-2032

Figure 80: Europe Market Attractiveness by Country, 2022-2032

Figure 81: South Asia Market Value (US$ Mn) by Test Type, 2022-2032

Figure 82: South Asia Market Value (US$ Mn) by Technology, 2022-2032

Figure 83: South Asia Market Value (US$ Mn) by End-user , 2022-2032

Figure 84: South Asia Market Value (US$ Mn) by Country, 2022-2032

Figure 85: South Asia Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: South Asia Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 89: South Asia Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 91: South Asia Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 92: South Asia Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 94: South Asia Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 95: South Asia Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 97: South Asia Market Attractiveness by Test Type, 2022-2032

Figure 98: South Asia Market Attractiveness by Technology, 2022-2032

Figure 99: South Asia Market Attractiveness by End-user , 2022-2032

Figure 100: South Asia Market Attractiveness by Country, 2022-2032

Figure 101: East Asia Market Value (US$ Mn) by Test Type, 2022-2032

Figure 102: East Asia Market Value (US$ Mn) by Technology, 2022-2032

Figure 103: East Asia Market Value (US$ Mn) by End-user , 2022-2032

Figure 104: East Asia Market Value (US$ Mn) by Country, 2022-2032

Figure 105: East Asia Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: East Asia Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 109: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 111: East Asia Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 112: East Asia Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 114: East Asia Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 115: East Asia Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 117: East Asia Market Attractiveness by Test Type, 2022-2032

Figure 118: East Asia Market Attractiveness by Technology, 2022-2032

Figure 119: East Asia Market Attractiveness by End-user , 2022-2032

Figure 120: East Asia Market Attractiveness by Country, 2022-2032

Figure 121: Oceania Market Value (US$ Mn) by Test Type, 2022-2032

Figure 122: Oceania Market Value (US$ Mn) by Technology, 2022-2032

Figure 123: Oceania Market Value (US$ Mn) by End-user , 2022-2032

Figure 124: Oceania Market Value (US$ Mn) by Country, 2022-2032

Figure 125: Oceania Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 128: Oceania Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 129: Oceania Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 131: Oceania Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 132: Oceania Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 134: Oceania Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 135: Oceania Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 137: Oceania Market Attractiveness by Test Type, 2022-2032

Figure 138: Oceania Market Attractiveness by Technology, 2022-2032

Figure 139: Oceania Market Attractiveness by End-user , 2022-2032

Figure 140: Oceania Market Attractiveness by Country, 2022-2032

Figure 141: MEA Market Value (US$ Mn) by Test Type, 2022-2032

Figure 142: MEA Market Value (US$ Mn) by Technology, 2022-2032

Figure 143: MEA Market Value (US$ Mn) by End-user , 2022-2032

Figure 144: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 145: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 148: MEA Market Value (US$ Mn) Analysis by Test Type, 2017-2032

Figure 149: MEA Market Value Share (%) and BPS Analysis by Test Type, 2022-2032

Figure 150: MEA Market Y-o-Y Growth (%) Projections by Test Type, 2022-2032

Figure 151: MEA Market Value (US$ Mn) Analysis by Technology, 2017-2032

Figure 152: MEA Market Value Share (%) and BPS Analysis by Technology, 2022-2032

Figure 153: MEA Market Y-o-Y Growth (%) Projections by Technology, 2022-2032

Figure 154: MEA Market Value (US$ Mn) Analysis by End-user , 2017-2032

Figure 155: MEA Market Value Share (%) and BPS Analysis by End-user , 2022-2032

Figure 156: MEA Market Y-o-Y Growth (%) Projections by End-user , 2022-2032

Figure 157: MEA Market Attractiveness by Test Type, 2022-2032

Figure 158: MEA Market Attractiveness by Technology, 2022-2032

Figure 159: MEA Market Attractiveness by End-user , 2022-2032

Figure 160: MEA Market Attractiveness by Country, 2022-2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Multiple Endocrine Neoplasia Market

Published : February 2019

Healthcare

Endocrine Peptides Test Market

Published : October 2017

Healthcare

Neuroendocrine Carcinoma Treatment Market

Published : March 2022

Healthcare

Endoscopy Visualization Components Market

Published : January 1970

Google translate

Endocrine Testing Market